Kenvue (NYSE: KVUE) grants 63,525 RSUs to Chief Scientific Officer

Rhea-AI Filing Summary

Kenvue Inc. reported that Chief Scientific Officer Caroline Tillett acquired 63,525 Restricted Stock Units as an equity award. The units were granted at no cash cost and correspond one-for-one with Kenvue common stock.

This award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, as long as Tillett continues to serve at the company through each vesting date. All 63,525 RSUs are currently reported as directly owned following the grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tillett Caroline

(Last) (First) (Middle)

1 KENVUE WAY

(Street)

SUMMIT NJ 07901

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kenvue Inc. [ KVUE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/02/2026		A		63,525		(2)	(2)	Common Stock	63,525	$0	63,525	D

Explanation of Responses:

1. These units correspond 1 for 1 with the Company's common stock.

2. This award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, subject to the reporting person's continued service through such vesting date.

Remarks:

	/s/ Alla Berenshteyn, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity award did Kenvue (KVUE) grant to Caroline Tillett?

Kenvue granted Chief Scientific Officer Caroline Tillett 63,525 Restricted Stock Units as an equity award. Each unit corresponds one-for-one with Kenvue common stock, giving her potential future ownership if vesting conditions tied to continued service are satisfied over time.

When do Caroline Tillett’s 63,525 Kenvue (KVUE) RSUs vest?

The 63,525 Restricted Stock Units vest in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029. Vesting is contingent on Tillett’s continued service with Kenvue through each respective vesting date described in the award terms.

How are Caroline Tillett’s Kenvue (KVUE) RSUs related to common stock?

Each Restricted Stock Unit awarded to Caroline Tillett corresponds one-for-one with a share of Kenvue common stock. This means that upon vesting and settlement, each RSU is designed to convert into a single share, aligning her compensation more closely with shareholder value.

Did Caroline Tillett pay cash for the 63,525 Kenvue (KVUE) RSUs?

No cash purchase was reported for the 63,525 Restricted Stock Units granted to Caroline Tillett. The units were acquired as a grant or award, which is a common form of stock-based compensation for senior executives in large public companies like Kenvue.

What is Caroline Tillett’s reported Kenvue (KVUE) RSU holding after this Form 4?

After this transaction, Caroline Tillett is reported as directly owning 63,525 Restricted Stock Units. These units are subject to the multi-year vesting schedule, so actual shares delivered will depend on her continued service with Kenvue through each scheduled vesting date.